bf/NASDAQ:ICVX_icon.jpeg

COM:ICOSAVAX

Icosavax, Inc.

  • Stock

15.31

−0.91%

−0.14

USD last updated 24/07 01:52:16

Last Close

15.45

16/02 21:00

Market Cap

769.04M

Beta: -

Volume Today

8.56M

Avg: -

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncyt...Show More